Ma Yinglong is a long-established Chinese enterprise recognized by the Ministry of Domestic Trade and was founded in 1582. Through continuous rapid and healthy development, Ma Yinglong has become a specialized, multi-functional and internationalized pharmaceutical listed company involved in pharmaceutical manufacturing, pharmaceutical research and development, pharmaceutical wholesaling and retailing, and chain hospitals.
Table of Contents
1 Introduction
2 Origins
3 Historical Achievements
4 Business Achievements
5 Leading Products
6 Listed Companies
7 Honors Received
8 Shareholding Reforms
9 Corporate Culture
Business Purpose
Philosophy
Philosophy
Values
Operational Outlook
Enterprise Spirit
10 Scope of Business
1 Introduction
Four hundred years of history - Ma Yinglong's lineage
Ma Yinglong Pharmaceutical Group Co. Ltd. (hereinafter referred to as "Ma Yinglong Pharmaceutical")[1] is a Chinese long-established enterprise with a history of more than four hundred years
Ma Yinglong
Founded in 1582 (the 10th year of the Wanli reign of the Ming Dynasty), Ma Jintang, the founder of Ma Yinglong, started his own small ophthalmic pharmacy, Ma Yinglong Shengji Pharmacy, in Dingxian County of Hebei Province, present-day Dingzhou City of Hebei Province, which was located at the heart of the city. In 1582, Ma Jintang, the founder of Ma Yinglong, opened a small eye pharmacy in Ding County, Hebei Province (present-day Dingzhou City, Hebei Province) (the main store was later moved to Beijing), and created the "Eight Treasures" eye medicine. In the Qianlong period of the Qing Dynasty, Ma Jintang's descendant, Ma Yinglong, named the "Eight Treasures Eye Medicine" as "Ma Yinglong Dingzhou Eye Medicine". For more than four hundred years, the Ma Yinglong brand has been passed down from generation to generation, composing a legendary story of "helping the world with a pot and a kind hand".
After the enterprise moved south to Wuhan in 1919, Ma Yinglong Shengji Pharmacy developed other series of products, and its production and operation developed rapidly, and won national awards from the Ministry of Agriculture and Commerce and the Ministry of Railway at that time, and its products gained a good reputation among the Chinese in Southeast Asia, and it became one of the earliest four major enterprises in China that exported commodities to overseas.
After the establishment of the People's Republic of China, Ma Yinglong Shengji Pharmacy became a wholly state-owned enterprise - Wuhan No. 3 Pharmaceutical Factory, which was restructured into Wuhan Ma Yinglong Pharmaceutical Co., Ltd. in 1993, and then operated under the control of China Bao'an Group, one of the earliest listed companies in China, through the transfer of state-owned shares in 1995. On May 16, 2008, the company name was changed to "Ma Yinglong Pharmaceutical Group Company Limited" by the 2007 annual shareholders' meeting.
2Origin
Because of its long history, in the process of organizing and researching the history of "Ma Yinglong" by us and our predecessors, we have not been able to find any historical materials and physical evidence related to the origin of Ma Yinglong. The origin of Ma Yinglong can only be understood from the folk legend that Ma Jingbiao, the ancestor of the Ma family, completed the creation of eye medicine in Dingzhou, Hebei Province during the Wanli period of the Ming Dynasty. Therefore, let's tentatively set the Wanli period of the Ming Dynasty as the predecessor of Ma Yinglong's eye medicine, i.e., the origin of Ma's eye medicine formula
.
In the craft industry of the Ming and Qing dynasties, there was a tradition of naming the name of the brand after the name of the father. This tradition was followed in the formation and development of Ma Yinglong. Ma's eye
Pharmaceuticals after several generations of inheritance, in the late Qing Dynasty, by Ma Wanxing to use his father Ma Yinglong's name as the name, and in the first year of the Qing dynasty Guangxu moved from Dingzhou, Hebei Province, to the Beijing Qianmen Xihuyan opened "Beijing Ma Yinglong eye pharmacy," and since then
After that, the Beijing Xihuyan has always been the center of the inheritance and production of the eye medicines of Ma Yinglong. Since then, Beijing Xiheyan has always been the center of Ma Yinglong's eye medicine inheritance and production.
Subsequently, Ma Wanxing's son, Ma Li (Li) Ting, in view of the fact that "Tong Ren Tang" always kept its name and its business became more and more prosperous, and realizing that consumers only recognized the name but not the person, he decided to break the tradition and use "Ma Yinglong" for generations after inheriting Beijing Ma Yinglong Ophthalmic Pharmacy. The name "Ma Yinglong" has been used for generations. Therefore, it can be said that it is the breakthrough innovation of Ma Li (Li) Pavilion and its understanding of the value of the brand that has enabled it to establish and ultimately
finally use the brand "Ma Yinglong". [2]
3Historical Achievements
Beijing is an important place for the development of Ma Yinglong ophthalmic medicine. The history of "Ma Yinglong" is also the history of Beijing Ma Yinglong Eye Pharmacy.
According to the records, the successor, Ma Li (Li) Ting, located the Beijing Ma Yinglong Ophthalmic Pharmacy at No. 52, Xiheyan, Qianmen, Beijing, in 1923 (the site of the store still exists, and the plaque can be seen vaguely
). And from 1930, successively through the establishment of branches and mail, Ma Yinglong eye medicine sales to Tianjin, Nanjing, Shanghai, Zhenjiang, Anhui, Henan, Hubei, Hunan, Jiangsu and other provinces and cities, realized
Ma Yinglong eye medicine to Beijing Ma Yinglong eye pharmacy as the center of the national large-scale promotion of breakthroughs, and through the friend of Mr. Wu Linge's referral for the export of European documents, pioneering the first Chinese medicine eye medicine to the United States, the first Chinese medicine eye medicine to the United States.
Ma Yinglong eye medicine has made a breakthrough in the large-scale promotion of the medicine nationwide, centering on the Beijing Ma Yinglong Eye Shop.
During the period of its operation, Beijing Ma Yinglong eye medicine has made remarkable achievements: in May of the 5th year of the Republic of China, it won the third prize of the Ministry of Agriculture and Commerce; in the 24th year of the Republic of China, it won the Certificate of Merit of the Ministry of Industry, and in the same year, it won the first prize of the Exhibition of the National Railway Products of the Ministry of Railway; in the 25th year of the Republic of China, it won the prize of the Nanjing Government; and in the 26th year of the Republic of China, it won the Medal of Panama Exposition of San Francisco of the United States, and so on.
Beijing Ma Yinglong through the efficacy of the medicine not only gained business success, but also won the recognition of Westerners to the Chinese traditional Chinese medicine and even Oriental culture.
According to the official website of Princeton University in the United States, Moore
Gest, an American engineer and donor of the university's Gest Oriental Library, used Ma Yinglong eye medicine to treat his eye disease in Beijing around the 1930s and achieved good results. He used Ma Yinglong eye medicine to cure his eye disease during his stay in Beijing around the 1930s, with good results. This led to the purchase of a collection of traditional Chinese medical books, which would become the first collection of the East Asian Library at Princeton
University.
4Business Performance
Ma Yinglong
Through the introduction of Bao'an Group's advanced management mechanism and concept in 1995, Ma Yinglong Pharmaceutical entered the fast track of coordinated development. Ltd. and Wuhan Ma Yinglong Pharmaceutical Co. Over the past ten years, Ma Yinglong Pharmaceutical has carried out a fruitful reform of the property right system, formed a diversified shareholding structure and a relatively perfect corporate governance structure, and continuously introduced advanced operation methods, management mechanisms and ideas. Ma Yinglong Pharmaceutical adheres to the brand management strategy, takes the market as the guide, strengthens the core competitiveness, takes the brand as the link, integrates the social resources, satisfies the customer demand, cultivates the customer loyalty, and advances with the times under the banner of brand; adheres to the capital management strategy, takes the industrial management as the basis, and takes the capital management as the means of extraordinary development; adheres to the alliance management strategy, establishes win-win We adhere to the alliance management strategy and establish win-win alliances with upstream, downstream, and domestic and foreign partners; we adhere to the integration of thick historical resources and long-lasting traditional concepts with innovative thinking. The modern management consciousness and the cultural tradition of cultivating the heart with truth and cultivating the mind with diligence formed by Ma Yinglong Pharmaceutical for more than four hundred years have been combined to form an interactive effect, which triggered the vitality of Ma Yinglong, and the economic indexes have been rising year by year, maintaining a positive growth of more than double-digit for ten consecutive years.
Ma Yinglong Pharmaceutical's production capacity, sales capacity and profitability have all increased by more than 10 times, and its operating net assets have increased by nearly 50 times. Over the past ten years, all kinds of equipment and facilities
facilities and working environment have undergone fundamental changes, and the rate of upgrading and reconstruction has reached 100%. Over the past ten years, the income of employees has increased by 3-18 times, and the jobs provided have quadrupled. Over the past ten years, the accumulated tax paid by Ma Yinglong Pharmaceutical
has reached 500 million yuan, and the value of shareholders' equity has increased by more than 50 times. Ma Yinglong Pharmaceutical ranked first in Hubei Province in terms of efficiency in the pharmaceutical industry, and was the first brand in the field of hemorrhoid drugs in China. As of December 31, 2005, the company's total assets amounted to 800 million yuan, gearing ratio is only about 20%.
The company as a whole passed the State Food and Drug Administration GMP (Good Manufacturing Practice) and GSP (Good Practice in Pharmaceutical Manufacturing) certifications, and was the first in the pharmaceutical industry to obtain the certification of the international authority issued by the environmental management system ISO14001 and occupational safety and health management system OHSAS18001. We have established a perfect marketing system and a nationwide sales network, and our products are exported to Southeast Asia, Europe and the United States. Ma Yinglong Pharmaceutical's brand reputation is growing, and it has become a leading brand in the field of hemorrhoid medication in China. Its Wuhan Ma Yinglong Pharmacy Chain Co., Ltd. is the first pharmaceutical retailing enterprise in Hubei Province to obtain GSP certificate, and is gradually growing into a famous brand of pharmaceutical retailing in central China. The technical strength and integration ability of drug research and development have been gradually improved, and the company has successfully developed the national Class I new drug "Guanzheng Methylin Hydrochloride", established long-term strategic cooperative relationships with a number of scientific research institutes, and has been awarded a post-doctoral workstation by the Ministry of Personnel of the People's Republic of China.
Despite the rapid growth of Ma Yinglong's pharmaceutical business, the company's profit contribution is limited due to the continuous decline in the overall gross profit margin of the pharmaceutical wholesale and retail sector.
5Leading Products
Ma Yinglong
The leading products of the pharmaceutical industry are Ma Yinglong Musk Hemorrhoid Ointment, Ma Yinglong Musk Hemorrhoid Suppository, Compound Licorice Combination and other medicines, whose hemorrhoid medicines have always been the leading medicines in the domestic market in the same kind of medicines, and the exclusive production of the skin medicines, Longzhu Ointment and Qiying Neiying Ointment, which are quite well known.
The company has been accelerated in the launch of a series of new hemorrhoid medicines in 2006, which is the first of its kind in China. In 2006, the company accelerated the launch of series of new drugs for hemorrhoids, such as oral (tablets, granules, capsules, etc.), injections, fumigation and physical devices, etc., to form a diversified variety of products and product series characteristics.
The company's market share of hemorrhoid drugs in the OTC remains above 50%, with a market share of
26%. Musk hemorrhoid cream basically monopolized the market of this dosage form, the share of the OTC market reached more than 80% and its sales scale has the potential to grow. Domestic market for hemorrhoids, cough medicine demand is
large, and the company's Ma Yinglong musk hemorrhoid cream, compound licorice syrup and other leading product quality, market awareness, and hemorrhoid products with the company also intends to use 8-10 years to set up a chain of anorectal hospitals in the country 5-8
chain. Ma Yinglong Longzhu ointment products are transformed from the Ma Yinglong family ancestral secret recipe, in the clinical stage due to good efficacy and demand exceeds supply, due to the skin disease is a common disease in China, frequent diseases, China's annual dermatological
Skin disease medication costs in the 600 million yuan or so, so it can be predicted that the product market prospects. 06 years to become China's hemorrhoids in the field of the only "China's well-known trademarks". In 2006, it became the only "China Famous Trademark" in the field of hemorrhoids in China, with a brand value of 2.813 billion yuan.
6 Listed Companies
Ma Yinglong
Ma Yinglong Pharmaceuticals has developed into a specialized and multi-functional pharmaceutical group listed on the stock code of 600993, with 10 subsidiaries, which is involved in various fields such as pharmaceutical production, pharmaceutical research and development, pharmaceutical wholesaling and retailing, etc.
Ma Yinglong Pharmaceuticals is the only company in the field of hemorrhoids in China.
In 2004, Ma Yinglong shares were successfully listed on the Shanghai Stock Exchange, realizing the goal of Ma Yinglong's capital securitization and marking Ma Yinglong's entry into a new stage of historical development. The listing of Ma Yinglong stock further strengthened the core competitiveness of Ma Yinglong Pharmaceuticals, enhanced the brand image of Ma Yinglong Pharmaceuticals, and provided Ma Yinglong Pharmaceuticals with a channel for sustained and rapid development as well as a platform for standardized and healthy operation. Since its listing, Ma Yinglong Pharmaceutical has been highly praised by investors for its good business performance and growth, with a high proportion of shares held by institutional investors, and its earnings per share in 2004 (RMB 1.03/share) and 2005 (RMB 1.17/share) ranked the first among the listed companies in the pharmaceutical industry in Shanghai and Shenzhen, and the listed companies in Hubei Province.
7Honors
Ma Yinglong
Ma Yinglong Pharmaceuticals has been recognized by the national and local governments as a "High-tech Enterprise", "Backbone Enterprise of the National TCM Modernization Industrial Base", "Quality Enterprise", "Quality Enterprise", "Quality Enterprise", "Quality Enterprise", "Quality Enterprise" and "Quality Enterprise". Ma Yinglong Pharmaceutical has been recognized by national and local governments as "High-tech Enterprise", "Backbone Enterprise of National Chinese Medicine Modernization Industrial Base", "Quality Winning Enterprise", "Advanced Enterprise in Economic Benefits", "China's 100 Most Respected Listed Companies", and has been praised as "a successful model of state-owned enterprise reform" and so on. Ma Yinglong brand was awarded "China's 500 Most Valuable Brands" (Ma Yinglong ranked 220th in the list of China's Most Valuable Brands in 2006 with a brand value of 2.831 billion yuan), and became the "Only Recommended Brand of Hemorrhoidal Drugs by China Anal and Intestinal Association", and "Ma Yinglong" is the only brand recommended by China Anal and Intestinal Association. "Ma Yinglong" trademark was named China Famous Trademark, Ma Yinglong Musk Hemorrhoid Cream has been named the best-selling product in the industry for many times, and Musk Hemorrhoid Suppository has been listed in the National Torch Program.
8Shareholding Reform
Ma Yinglong
Wuhan Ma Yinglong Pharmaceutical Group Co., Ltd. is a joint-stock limited company established on May 9, 1994, and registered with Wuhan Administration for Industry and Commerce. The predecessor of the Company was Wuhan No. 3 Pharmaceutical Factory, which was set up by way of directional solicitation with the approval of Wuhan Municipal Economic System Reform Commission under the document "Wuhan Body Reform [1993] No. 189" On March 20, 2004, Wuhan Ma Yinglong Pharmaceutical Group Company Limited was approved to issue shares by China Securities Regulatory Commission through the Circular of Securities Regulatory Issuance Zi (证监发行字) ("Circular of Securities Regulatory Issuance Zi"). On March 20, 2004, with the approval of China Securities Regulatory Commission's "Notice on Approval of Public Offering of Shares of Wuhan Ma Yinglong Pharmaceutical Group Company Limited" (《關於批准的通知》), the company issued 18 million shares of RMB common stock, which were listed and traded in Shanghai Stock Exchange on May 17, 2004. After the issue, the share capital of the company increased to 51,169,740,000 shares, of which 9,000,000 shares were state shares, 23,578,888,000 shares were legal person shares, 590,860,000 shares were individual shares, and 18,000,000 shares were RMB common shares. on August 13, 2004, Wuhan Huahan Investment Management Co., Ltd. and Wuhan Eastlake Innovation and Technology Investment Co., Ltd. signed the "Legal Person Shares Equity Transfer Contract". Wuhan Huahan Investment Management Co., Ltd. transferred its 2.6 million legal person shares of the Company to Wuhan East Lake Innovation and Technology Investment Co., Ltd. at a price of RMB 9.41 per share.
Honorary certificates awarded to Ma Yinglong(5)
On March 19, 2005, Wuhan East Lake Innovation Science and Technology Investment Co., Ltd. transferred 3.8 million legal person shares (accounting for 7.43% of the total share capital of the Company) held by Wuhan East Lake Innovation Science and Technology Investment Co., Ltd. to a shareholder of the Company, Wuhan Hua Han Investment Management Co. On June 3, 2005, the registration and transfer procedures of the transfer of corporate shares were completed.
On July 19, 2006, the Company implemented the equity distribution reform, and the outstanding shares were changed from the original 18 million shares to 21.6 million shares, and the non-outstanding shares were changed from the original 33,169,740,000 shares to 29,569,740,000 shares with limited selling conditions.
On May 19, 2007, the 2006 annual profit distribution plan was approved by the 2006 annual shareholders' meeting, based on the total share capital of 51,169,740 shares at the end of 2006, with a bonus of RMB 3 (tax included) for every 10 shares, the share capital of the company was changed to 61,403,688 shares, of which 35,483,688 shares were restricted shares and 25,920,688 shares were non-restricted shares. The share capital of the Company was changed to 61,403,688 shares, of which 35,483,688 were limited shares and 25,920,000 were unlimited shares.
The Company's name was changed from Wuhan Ma Yinglong Pharmaceutical Group Company Limited to
Ma Yinglong Pharmaceutical Group Company Limited on May 16, 2008 after the approval of the 2007 annual general meeting.
"Ma Yinglong Pharmaceutical Group Co. The corresponding industrial and commercial approval and industrial and commercial change procedures for the change of the Company's name have all been completed. On May 30, 2008, the Company obtained a new business license from the Wuhan Administration for Industry and Commerce, and on June 2, 2008, the new official seal of the Company came into effect. The short name of the securities remains unchanged.
9Corporate Culture
Business Purpose
Creating Health for Customers Creating Wealth for Shareholders
Creating Opportunities for Employees Creating Benefits for Society
Maying Dragon
Substantiation:The essence of the business purpose is to make all kinds of interest subjects obtain sustainable, fair and maximized benefits through the management of Maying Dragon, which constitutes a a solid platform of interest relations.
Logic: The business purpose consists of four aspects, which are closely related to each other. Its internal logic is that only by creating health for customers can we realize wealth appreciation for shareholders, which in turn provides development opportunities for employees and ultimately realizes social benefits.
Connotation: Diversification of the main body of interests; long-term pursuit of interests; fairness in the principle of distribution; and maximization of returns on inputs.
Philosophy
HistoryThe philosophy of "Cultivating the heart with sincerity and cultivating the mind with diligence" is the crystallization of Ma Yinglong's history and culture for more than 400 years. Sincerity and truthfulness as a person, diligence and down-to-earth work.
Truthfulness "is really the first spirit." When concocting medicines, we must seek real materials, when dealing with people, we must seek sincerity, when treating people, we must seek truth and sincerity, when studying and exploring, we must seek truthfulness, when discussing and researching, we must seek truthfulness, and when evaluating and summarizing, we must seek truthfulness.
Diligence "Diligence is the first method." The way of heaven rewards diligence, a plow, a harvest. Any method, no matter how subtle, must start with diligence. To do anything, must be diligent and hardworking, must be down-to-earth, must be meticulous, must be self-improvement.
Values
Connotation: Value-added is directly manifested in creation, innovation, contribution and progress, and indirectly manifested in the sustainable and fair maximization of value-added benefits for all subjects of interest.
Significance: value-added resources is the intrinsic value requirement of enterprise operation. Whether or not to realize the value-added resources is the main criterion to measure the enterprise value and personal value.
Key: Focus on the balance of efficiency and effectiveness Focus on the ratio of inputs and outputs Focus on the assessment of increment and contribution
Operational Outlook
Stable Management and Coordinated Development
Coordination: Establish a scientific outlook on development - Focus on the coordination of the main body of interests, business elements, and business capacity - Focus on long-term benefits and the pursuit of sustainable development - Steady, down-to-earth, and balanced in all respects steady, down-to-earth, and balanced in all aspects
Soundness: Respecting laws, opposing speculation, and making scientific decisions - Implementing sound financial policies, and pursuing effective business results - Taking quantitative control as the main management tool, and communication and coordination as the core management link
Enterprise Spirit
Dragon & Horse Spirit
Dragon & Horse Spirit in Ma Yinglong, the dragon symbolizes ambitious ideals, firm beliefs, perseverance in pursuing, discovering the laws and mastering them, and keeping abreast of the times. harness the laws, advance with the times, and deal with the relationship between man and nature, man and society.
The horse symbolizes being down-to-earth, accumulating virtues with a tolerant mind, respecting the laws and at the same time conforming to them, being sincere and truthful, and doing things diligently and practically. Ying, that is, the echo of the dragon and the horse, symbolizes the combination of tolerance, piety and the spirit of practicality, vigor and upward mobility, and the combination of ambitious ideals and practicality.
Ma Yinglong advocates the "Dragon and Horse Spirit", that is, the pursuit of the moral character of the horse and the spirit of the dragon, the pursuit of the unity of behavior and philosophy, pragmatism and pragmatic, the pursuit of the harmony of the relationship between man and heaven - physiological health, the so-called unity of heaven and man; the pursuit of the harmony of interpersonal relationships - psychological health, the so-called benevolence and love of man. -psychological health, the so-called benevolence and love.
10 Business Scope
Manufacture of Chinese and Western medicines; the enterprise operates the export business of the enterprise's self-produced products and related technologies; operates the import and export business of raw and auxiliary materials, machinery and equipment, instruments and meters, spare parts and related technologies for the production and scientific research of the enterprise; operates the processing of the enterprise's incoming raw materials and the "three to one complementary "business; operating one, two, three types of medical equipment. Part-time crystal drinks; plastic bottles, cosmetics, Chinese medicine pharmaceutical machinery manufacturing, processing, sales; automobile freight.